Yardeni Forecasts Potential July Rate Hike as Bond Vigilantes Pressure Incoming Fed Chair Warsh AI Wealth Must Serve Public Good South Koreas Deputy PM Warns Amid Samsung Labor Unrest The Pitfalls of Performance Chasing Why LongTerm Strategy Matters Over ShortTerm Returns Wealth Concealment and Social Dynamics Financial Honesty Among Friends Indias Gherkin Exports Reach Record 307 Million in FY26 Defying US Tariffs How Technology Is Shaping a New Era of Healthcare Innovation HTB Q1 2026 Earnings EPS Surges Past Estimates with a 20 Beat FULTP Q1 2026 Earnings Preferred Stock Delivers EPS Beat Despite Market Headwinds LIVE Q1 2026 Earnings Profitability Achieved Amidst Challenging Environment PRK Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Higher XOMA Q1 2026 Earnings Royalty Revenue Challenges Lead to EPS Miss Stock Slips Kontoor Brands Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick Gilat Satellite Networks GILT Declines 4 as Stock Tests Key Support Levels Moolec Science MLEC Slides 44 Amid Selling Pressure Key Support at 706 in Focus Chiron Real Estate Inc XRN Holds Steady Near 3742 as Support and Resistance Levels Remain Key IGC Pharma Holds Steady at 029 as Stock Consolidates Near Key Levels Molina Healthcare MOH Slides 43 as Sector Headwinds Weigh on Sentiment Silver Price Outlook Key Drivers and Market Expectations for the Next Decade BH Q1 2025 Earnings EPS of 2337 Reported Amid Limited Disclosure Air Lease Corporation AL Holds Steady at 65 as Key Levels Define Trading Range Passage Bio Q1 2026 Earnings Narrowerthanexpected loss signals disciplined spending PRCT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment GEVO Q1 2026 Earnings Significant EPS Miss Amid Operational Transition OrthoPediatrics Corp KIDS Q1 2026 Earnings NarrowerThanExpected Loss Surprises Market Mirion Technologies Q1 2026 Earnings EPS Beats Estimates Stock Rises Over 4 XOMAP Q1 2026 Earnings Perpetual Preferred Faces Steep EPS Miss Amid Limited Revenue Visibility Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development